In this comprehensive analysis of putative LSC marker, we have identified GPR56 and CLL‐1 to be the most prominently differently expressed surface markers in AML CD34/38 subcompartments at diagnosis. The gene discussed is CLEC12A; the disease is acute myeloid leukemia.